Asset Details
Do you wish to reserve the book?
Calprotectin, Calgranulin C, and Other Members of the S100 Protein Family in Inflammatory Bowel Disease
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Calprotectin, Calgranulin C, and Other Members of the S100 Protein Family in Inflammatory Bowel Disease
Do you wish to request the book?
Calprotectin, Calgranulin C, and Other Members of the S100 Protein Family in Inflammatory Bowel Disease
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Calprotectin, Calgranulin C, and Other Members of the S100 Protein Family in Inflammatory Bowel Disease
2011
Overview
Background
Since their discovery, S100 proteins have been associated with diverse diseases of inflammatory, degenerative, or malignant nature. Due to their participation in inflammation, they have also been studied with regard to inflammatory bowel disease (IBD).
Method
To provide a review of available literature, a PubMed, MEDLINE, and Embase-based literature search was performed, using all available nomenclature for each member of the S100 protein family, along with the terms inflammatory bowel disease, ulcerative colitis, Crohn’s disease, or indeterminate colitis.
Result
S100A8/A9, also known as calprotectin, S100A12, or calgranulin C and in a lesser extent S100P, are involved in the pathogenesis, activity, diagnosis, and therapeutic management of IBD. The majority of available literature is focused primarily on S100A8/9, although there is growing evidence on the significance of S100A12. Most studies emphasize the potential merit of S100A8/A9 and S100A12, as markers for differential diagnosis, monitoring of activity, or disease relapse, in IBD. Limitations, regarding the diagnostic utility of these markers, seem to exist and are mainly related to the publication of conflicting results, i.e., for IBD activity, and to the fact that S100A8/A9 and S100A12 are not disease-specific.
Conclusions
Although the existing data link specific S100 proteins with IBD, there are still several drawbacks in the use of these markers for diagnostic purposes. Thus, it seems that further research is mandatory in order to eliminate the impact of confounding factors but also to detect additional associations between S100 proteins and IBD or novel S100 proteins with a closer correlation with IBD.
Publisher
Springer US,Springer,Springer Nature B.V
Subject
/ Biological and medical sciences
/ Fundamental and applied biological sciences. Psychology
/ Gastroenterology. Liver. Pancreas. Abdomen
/ Gene Expression Regulation - physiology
/ Humans
/ Inflammatory Bowel Diseases - genetics
/ Inflammatory Bowel Diseases - metabolism
/ Medicine
/ Oncology
/ Proteins
/ Review
/ Stomach. Duodenum. Small intestine. Colon. Rectum. Anus
/ Vertebrates: anatomy and physiology, studies on body, several organs or systems
